Congress Proposes Doubling Research Grants for Small Businesses to Boost Innovation and Security
This bill is currently sitting in the House Committee on Small Business and the House Committee on Science, Space, and Technology. It has not moved since April 2025, and no action has been taken on it for 14 months. The bill is considered stalled because the committees have not scheduled any votes or hearings.
No action since May 2025
This bill’s path across every version that has carried it.
Reintroduced
Reintroduced from H.R. 10407 (118th), which died when its Congress ended.
H.R. 10407 (118th) →Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
The bill's foreign ownership restrictions could affect small businesses with significant foreign investor involvement, which sometimes includes visa holders who have founded or co-founded tech startups. Companies majority-owned by entities connected to designated foreign countries of concern would be barred from SBIR awards. This could limit opportunities for some visa-holding entrepreneurs while also protecting the integrity of the program.
Referred to the Committee on Small Business, and in addition to the Committee on Science, Space, and Technology, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.

Sen. Ed Markey and Rep. Nydia Velázquez introduced the SBIR/STTR Reauthorization Act of 2025 to make the programs permanent and increase research funding. The bill would double agency set-asides to 7% for SBIR and 1% for STTR over seven years to provide long-term certainty for small innovators.
The House Small Business Committee unanimously advanced a one-year extension of the SBIR/STTR programs. However, Senate Small Business Chair Joni Ernst opposes the 'clean' extension, pushing instead for the INNOVATE Act to reform 'SBIR mills' and strengthen foreign influence safeguards.

Biotech and medtech startups face a 'valley of death' as Congress debates competing SBIR reauthorization bills. The Markey-Velázquez bill seeks to expand the program to 7% of R&D budgets, while the Ernst bill focuses on structural reforms and cutting STTR funding to prioritize first-time winners.
No votes recorded for this bill yet.
Document Type
Congressional Bill
Official Title
SBIR/STTR Reauthorization Act of 2025
Analysis generated by AI. Always verify with official sources.